GRAL GRAIL, Inc. - Common Stock
À propos de GRAIL, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
Lire la suite
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.
Activities
Illumina's own research showed that repeatedly sequencing DNA in the bloodstream made it possible to detect floating bits of DNA from cancer cells more accurately. It initially aimed to recruit greater than 100,000 people into its clinical trials in order to accumulate the sizeable data required to detect and interpret cancer biomarkers.
Galleri test
As of November 2020 Galleri investigated three multi-cancer screening tests.
In June 2021 Galleri launched their liquid biopsy or multi-cancer early detection test (MCED), which Grail called the Galleri test. Grail promoted the test as a "groundbreaking and potentially life-saving advance", although the results of early trials were poor. A subsequent large-scale NHS England trial was described as overhyped and unethical. As of 2024, Grail was facing discontent and legal action from investors.
In June 2025, an article in the New Yorker discussed an interview of their medicine and science writer regarding the test and its recent history with a focus on its potential for adaptation as research continues in its product development through clinical investigations.
On 17 October 2025, BBC news carried positive coverage of test results just presented at the European Society for Medical Oncology. However, as of October 20, 2025 the results of the PATHFINDER 2 study have yet to be peer reviewed or published. Eric Topol reported a sensitivity of only 40% these false negatives failed to discover cancer that emerged during the 12-month follow-up.
Company history
Grail began as a San Francisco biotechnology and pharmaceutical startup company in 2015, the parent company being Illumina of San Diego, which produces most of the DNA sequencing machines that scientists use to study human biology and diagnose rare genetic diseases. Richard Klausner, then chief medical officer at Illumina and former director of the National Cancer Institute, advocated for the new business. According to the San Francisco Business Times, he correctly predicted how DNA sequencing technology would make it possible to detect evidence of a tumor from a blood sample. He also joined Grail's board of directors. According to Forbes in 2017, 20% of Grail's profits are kept by Illumina.
In September 2020, Illumina announced an agreement to purchase Grail outright for $7.1 billion.
On November 27, 2020, Grail announced a commercial partnership with the National Health Service (England) (NHS), to trial the Galleri test, reporting in 2026.
In March 2021, the Federal Trade Commission (FTC) sued to block the vertical merger. In September 2022, an administrative judge ruled against the FTC's position on antitrust grounds.
In June 2023, Grail disclosed that letters were mailed to 408 patients incorrectly informing them that they may have cancer. The company blamed the incident on PWNHealth, saying that it was due to a software configuration issue, not due to incorrect Galleri test results.
In October 2023, the European Commission ordered Grail to be divested from Illumina within the next twelve months. The European Commission (EC) has since approved Illumina's divestment plan for separating from Grail. Illumina has set a goal of finalizing the divestment terms by the end of the second quarter of 2024. In April 2024, the EC approved Illumina's plan, allowing Illumina to explore either a trade sale or a capital markets transaction (spin-off) to divest Grail. In May 2024, Illumina publicly filed a Form 10 registration statement with the U.S. SEC, a necessary step for a potential capital markets separation of Grail. If a capital markets transaction occurs, Illumina must capitalize Grail with around $1 billion to fund 2.5 years of operations per the EC's divestment plan. The spinoff was completed in June 2024, with Grail trading on the Nasdaq with ticker symbol GRAL and Illumina retaining a 14.5% share of Grail.
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
GRAL Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
GRAL Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
GRAL Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
- Achat fort 4 26,7%
- Achat 5 33,3%
- Conserver 6 40,0%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
8 analystes · 2026-08-19Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-2.56 | $-2.71 | 0.15% |
| 31 mars 2026 | $-2.29 | $-2.82 | 0.53% |
| 31 décembre 2025 | $-2.44 | $-2.76 | 0.32% |
| 30 septembre 2025 | $-2.46 | $-3.59 | 1.1% |
| 30 juin 2025 | $-3.18 | $-3.64 | 0.46% |
| 31 mars 2025 | $-3.10 | $-4.17 | 1.1% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $147M | $126M | $93M | |
| R&D Expense | $196M | $322M | $339M | |
| SG&A Expense | $159M | $214M | $200M | |
| Operating Expenses | $709M | $2.31B | $1.61B | |
| Operating Income | $-562M | $-2.19B | $-1.52B | |
| Interest Income | $29M | $27M | $8M | |
| Other Non-op | $-993.0K | $64.0K | $-208.0K | |
| Pretax Income | $-535M | $-2.16B | $-1.51B | |
| Income Tax | $-126M | $-135M | $-42M | |
| Net Income | $-408M | $-2.03B | $-1.47B | |
| EPS (Basic) | $-11.11 | $-63.54 | $-47.21 | |
| EPS (Diluted) | $-11.11 | $-63.54 | $-47.21 | |
| Shares (Basic) | 36,753,751 | 31,901,259 | 31,049,148 | |
| Shares (Diluted) | 36,753,751 | 31,901,259 | 31,049,148 | |
| EBITDA | $-562M | $-2.19B | · |
Bilan 25
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $250M | $214M | $97M | |
| Receivables | $18M | $20M | $17M | |
| Prepaid Expense | $15M | $17M | $20M | |
| Current Assets | $954M | $820M | $156M | |
| PP&E (Net) | $52M | $69M | $85M | |
| PP&E (Gross) | $122M | $123M | $121M | |
| Accum. Depreciation | $70M | $54M | $36M | |
| Goodwill | · | $0 | $889M | |
| Intangibles | $1.85B | $2.02B | $2.69B | |
| Other Non-current Assets | $7M | $8M | $8M | |
| Total Assets | $2.92B | $2.98B | $3.91B | |
| Accounts Payable | $2M | $5M | $20M | |
| Accrued Liabilities | $64M | $57M | $74M | |
| Current Liabilities | $80M | $77M | $164M | |
| Capital Leases | $43M | $55M | $70M | |
| Deferred Tax | $219M | $346M | $33M | |
| Other Non-current Liabilities | $3M | $2M | $1M | |
| Total Liabilities | $344M | $480M | $268M | |
| Common Stock | $40.0K | $34.0K | · | |
| Paid-in Capital | $12.79B | $12.31B | · | |
| Retained Earnings | $-10.21B | $-9.80B | $-7.78B | |
| AOCI | $3M | $1M | $1M | |
| Stockholders' Equity | $2.58B | $2.50B | · | |
| Liabilities + Equity | $2.92B | $2.98B | $3.91B | |
| Shares Outstanding | 40,331,360 | 33,893,409,000 | 0 |
Flux de trésorerie 10
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $58M | $86M | $97M | |
| Deferred Tax | $-126M | $-134M | $-38M | |
| Amort. of Intangibles | $134M | $134M | $134M | |
| Operating Cash Flow | $-299M | $-577M | $-596M | |
| CapEx | $909.0K | $5M | $13M | |
| Investing Cash Flow | $-85M | $-551M | $-13M | |
| Financing Cash Flow | $423M | $1.24B | $464M | |
| Net Change in Cash | $39M | $116M | $-145M | |
| Taxes Paid | $1M | · | · | |
| Free Cash Flow | $-300M | $-582M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -382.0% | -1743.0% | · | |
| Net Margin | -277.5% | -1613.9% | · | |
| Pretax Margin | -363.2% | -1721.7% | · | |
| EBITDA Margin | -382.0% | -1743.0% | · | |
| ROA | -13.8% | -58.8% | · | |
| ROE | -16.7% | -79.6% | · | |
| ROIC | -16.7% | -82.0% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.0 | 10.7 | · | |
| Quick Ratio | 3.4 | 3.0 | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | |
| Receivables Turnover | 7.6 | 6.7 | · |
Taux de croissance 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 17.2% | 34.9% | 67.6% | |
| Revenue CAGR 3Y | 38.4% | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $147M | $126M | · | |
| Net Income TTM | $-408M | $-2.03B | · | |
| Market Cap | $3.45B | $605M | · | |
| P/E | -7.7 | -0.3 | · | |
| P/S | 23.5 | 4.8 | · | |
| P/B | 1.3 | 0.2 | · | |
| P / Tangible Book | 4.7 | 1.2 | · | |
| P / Cash Flow | -11.5 | -1.0 | · | |
| P / FCF | -11.5 | -1.0 | · | |
| Earnings Yield | -13.0% | -356.0% | · |
Compte de résultat 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $41M | $44M | $36M | $36M | $32M | $38M | $29M | $32M | $27M | $30M | $21M | |
| R&D Expense | $47M | $48M | $47M | $49M | $47M | $54M | $48M | $78M | $94M | $102M | · | · | |
| SG&A Expense | $51M | $43M | $39M | $37M | $38M | $45M | $42M | $47M | $67M | $57M | · | · | |
| Operating Expenses | $218M | $177M | $168M | $161M | $194M | $185M | $175M | $212M | $1.67B | $254M | $225M | $933M | |
| Operating Income | $-174M | $-136M | $-124M | $-125M | $-159M | $-154M | $-137M | $-184M | $-1.64B | $-227M | $-195M | $-912M | |
| Interest Income | $7M | $8M | $8M | $6M | $7M | $8M | $9M | $12M | $3M | $3M | $1M | $3M | |
| Other Non-op | $-155.0K | $256.0K | $-64.0K | $466.0K | $-811.0K | $-584.0K | $578.0K | $-561.0K | $5.0K | $42.0K | $213.0K | $-196.0K | |
| Pretax Income | $-167M | $-128M | $-117M | $-119M | $-153M | $-146M | $-127M | $-172M | $-1.64B | $-224M | $-193M | $-910M | |
| Income Tax | $-56M | $-34M | $-17M | $-30M | $-39M | $-40M | $-30M | $-47M | $-53M | $-6M | $-6M | $-19M | |
| Net Income | $-110M | $-93M | $-99M | $-89M | $-114M | $-106M | $-97M | $-126M | $-1.59B | $-219M | $-885M | $-891M | |
| EPS (Basic) | $-2.56 | $-2.29 | $-2.37 | $-2.46 | $-3.18 | $-3.10 | $-1.49 | $-3.94 | $-51.06 | $-7.05 | $-6.04 | $-28.71 | |
| EPS (Diluted) | $-2.56 | $-2.29 | $-2.37 | $-2.46 | $-3.18 | $-3.10 | $-1.49 | $-3.94 | $-51.06 | $-7.05 | $-6.04 | $-28.71 | |
| Shares (Basic) | 43,112,595 | 40,640,879 | -69,472,094 | 36,124,256 | 35,793,154 | 34,308,435 | -62,077,091 | 31,880,054 | 31,049,148 | 31,049,148 | 0 | 0 | |
| Shares (Diluted) | 43,112,595 | 40,640,879 | -69,472,094 | 36,124,256 | 35,793,154 | 34,308,435 | -62,077,091 | 31,880,054 | 31,049,148 | 31,049,148 | 0 | 0 | |
| EBITDA | $-174M | $-136M | · | $-125M | $-159M | $-154M | · | $-184M | $-1.64B | · | · | · |
Bilan 25
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $69M | $250M | $127M | $127M | $134M | $214M | $854M | $959M | · | $97M | · | |
| Receivables | $20M | $20M | $18M | $16M | $16M | $19M | $20M | · | · | · | · | · | |
| Prepaid Expense | $16M | $17M | $15M | $15M | $13M | $15M | $17M | $20M | $21M | · | · | · | |
| Current Assets | $915M | $877M | $954M | $589M | $652M | $728M | $820M | $910M | $1.02B | · | · | · | |
| PP&E (Net) | $44M | $48M | $52M | $56M | $60M | $65M | $69M | · | · | · | · | · | |
| PP&E (Gross) | · | · | $122M | · | · | · | $123M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $70M | · | · | · | $54M | · | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | · | $889M | · | |
| Intangibles | $1.78B | $1.82B | $1.85B | $1.89B | $1.92B | $1.98B | $2.02B | $2.05B | $2.09B | · | · | · | |
| Other Non-current Assets | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $8M | $8M | · | · | · | |
| Total Assets | $2.84B | $2.80B | $2.92B | $2.60B | $2.70B | $2.85B | $2.98B | $3.12B | $3.27B | · | · | · | |
| Accounts Payable | $7M | $5M | $2M | $3M | $6M | $6M | $5M | · | · | · | · | · | |
| Accrued Liabilities | $64M | $58M | $64M | $58M | $49M | $54M | $57M | $69M | $57M | · | · | · | |
| Current Liabilities | $84M | $75M | $80M | $77M | $71M | $75M | $77M | $94M | $88M | · | · | · | |
| Capital Leases | $81M | $41M | $43M | $45M | $48M | $51M | $55M | $59M | $62M | · | · | · | |
| Deferred Tax | $134M | $184M | $219M | $236M | $266M | $305M | $346M | $375M | $422M | · | · | · | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | · | · | · | |
| Total Liabilities | $301M | $303M | $344M | $361M | $388M | $434M | $480M | $530M | $575M | · | · | · | |
| Common Stock | $45.0K | $41.0K | $40.0K | $36.0K | $36.0K | $35.0K | $34.0K | $33.0K | $31.0K | · | · | · | |
| Paid-in Capital | $12.96B | $12.80B | $12.79B | $12.35B | $12.34B | $12.32B | $12.31B | $12.29B | $12.27B | · | · | · | |
| Retained Earnings | $-10.42B | $-10.30B | $-10.21B | $-10.11B | $-10.02B | $-9.91B | $-9.80B | $-9.71B | $-9.58B | · | · | · | |
| AOCI | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $2M | $1M | · | · | · | |
| Stockholders' Equity | $2.54B | $2.50B | $2.58B | $2.24B | $2.31B | $2.41B | $2.50B | $2.59B | $2.70B | · | · | · | |
| Liabilities + Equity | $2.84B | $2.80B | $2.92B | $2.60B | $2.70B | $2.85B | $2.98B | $3.12B | $3.27B | · | · | · | |
| Shares Outstanding | 44,666,234 | 41,134,219 | 40,331,360 | 36,160,998 | 36,047,799 | 35,296,858 | 33,893,409 | 33,203,744 | 31,049,148 | · | 0 | · |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $20M | $17M | $14M | $14M | $14M | $16M | $14M | $17M | $26M | $29M | $25M | $25M | |
| Deferred Tax | $-57M | $-35M | $-17M | $-30M | $-39M | $-40M | $-29M | $-47M | $-53M | $-5M | $-4M | $-18M | |
| Amort. of Intangibles | $33M | $33M | $30M | $35M | $33M | $33M | $30M | $35M | $35M | $35M | $30M | $35M | |
| Restructuring | · | · | · | · | · | · | · | $19M | · | · | · | · | |
| Operating Cash Flow | $-81M | $-87M | $-64M | $-63M | $-77M | $-95M | $-93M | $-105M | $-172M | $-207M | $-129M | $-158M | |
| CapEx | $432.0K | $503.0K | $94.0K | $384.0K | $369.0K | $62.0K | $303.0K | $971.0K | $1M | $3M | · | · | |
| Investing Cash Flow | $-47M | $-93M | $-237M | $67M | $70M | $15M | $-546M | $-971.0K | $-1M | $-3M | $-4M | $-3M | |
| Financing Cash Flow | · | · | $423M | $0 | $0 | $0 | $0 | $0 | $932M | $312M | $86M | $74M | |
| Net Change in Cash | $-14M | $-180M | $123M | $3M | $-6M | $-80M | $-640M | $-105M | $759M | $102M | $-47M | $-87M | |
| Free Cash Flow | · | $-87M | · | · | · | $-95M | · | · | · | · | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -388.9% | -332.9% | · | -346.2% | -446.9% | -482.5% | · | -640.5% | -5133.9% | · | · | · | |
| Net Margin | -246.7% | -228.5% | · | -245.8% | -320.7% | -333.6% | · | -438.7% | -4958.8% | · | · | · | |
| Pretax Margin | -373.1% | -312.7% | · | -328.0% | -430.1% | -459.9% | · | -601.7% | -5125.1% | · | · | · | |
| EBITDA Margin | -388.9% | -332.9% | · | -346.2% | -446.9% | -482.5% | · | -640.5% | -5133.9% | · | · | · | |
| ROA | -4.0% | -3.3% | · | -3.1% | -3.8% | -7.5% | · | -8.1% | -97.0% | · | · | · | |
| ROE | -4.5% | -3.8% | · | -3.7% | -4.5% | -8.8% | · | -9.7% | -117.6% | · | · | · | |
| ROIC | -4.5% | -4.0% | · | -4.2% | -5.1% | -4.6% | · | -5.2% | -58.9% | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 11.7 | · | 7.6 | 9.2 | 9.7 | · | 9.7 | 11.6 | · | · | · | |
| Quick Ratio | 0.9 | 1.2 | · | 1.8 | 2.0 | 2.0 | · | 9.1 | 10.9 | · | · | · |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Receivables Turnover | 2.5 | 2.1 | · | 4.4 | 4.4 | 3.3 | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $157M | $144M | · | $132M | $128M | $119M | · | $108M | $102M | · | · | · | |
| Net Income TTM | $-406M | $-402M | · | $-435M | $-1.93B | $-2.04B | · | $-2.82B | $-2.89B | · | · | · | |
| Market Cap | $3.05B | $2.13B | · | $2.14B | $1.85B | $901M | · | $457M | $477M | · | · | · | |
| P/E | -6.5 | -4.7 | · | -4.7 | -0.8 | -0.4 | · | -0.2 | -0.2 | · | · | · | |
| P/S | 19.4 | 14.7 | · | 16.2 | 14.5 | 7.6 | · | 4.2 | 4.7 | · | · | · | |
| P/B | 1.2 | 0.9 | · | 1.0 | 0.8 | 0.4 | · | 0.2 | 0.2 | · | · | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 6.0 | 4.7 | 2.1 | · | 0.9 | 0.8 | · | · | · | |
| P / Cash Flow | · | -24.4 | · | · | · | -9.5 | · | · | · | · | · | · | |
| P / FCF | · | -24.3 | · | · | · | -9.5 | · | · | · | · | · | · | |
| Earnings Yield | -15.4% | -21.3% | · | -21.4% | -119.2% | -255.1% | · | -659.6% | -605.3% | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-01 | |
|---|---|---|---|---|
| Revenu | $147M | $126M | $93M | $56M |
| Marge d'exploitation % | -382.0% | -1743.0% | — | — |
| Résultat net | $-408M | $-2.03B | $-1.47B | $-5.40B |
| BPA dilué | $-11.11 | $-63.54 | $-47.21 | $-173.89 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-01 | |
|---|---|---|---|---|
| Ratio de liquidité | 12.0 | 10.7 | — | — |
| Ratio de liquidité réduite | 3.4 | 3.0 | — | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-01 | |
|---|---|---|---|---|
| Flux de trésorerie libre | $-300M | $-582M | — | — |
Dernières actualités Actualités récentes mentionnant cette entreprise
- Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?
- Voici pourquoi l'action Grail a connu une forte hausse cette semaine
- Cet investisseur s'est retiré d'une participation de 22 millions de dollars dans GRAIL avant un krach boursier de 50 % en une journée le mois dernier
- Here's Why Grail Shares Crushed the Market This Week
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 411 déclarants · $2.2B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 67 (+16 vs T. préc.) | 45 (-49 vs T. préc.) | 106 (+8 vs T. préc.) | 102 (-12 vs T. préc.) | +6.7M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $284 111 340 | 4 161 584 | 13,20% | Actions |
| BAKER BROS. ADVISORS LP | $275 033 478 | 4 028 614 | 12,78% | Actions |
| STATE STREET CORP | $162 859 041 | 2 385 514 | 7,57% | Actions |
| PRIMECAP MANAGEMENT CO/CA/ | $148 835 838 | 2 180 106 | 6,91% | Actions |
| Sessa Capital IM, L.P. | $139 101 354 | 2 037 518 | 6,46% | Actions |
| Deep Track Capital, LP | $125 271 627 | 1 834 944 | 5,82% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $112 039 058 | 1 641 117 | 5,21% | Actions |
| Arbiter Partners Capital Management LLC | $70 611 456 | 1 034 297 | 3,28% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $58 460 697 | 856 182 | 2,72% | Actions |
| Jefferies Financial Group Inc. | $49 427 480 | 724 000 | 2,30% | Actions |
| Jefferies Financial Group Inc. | $44 375 500 | 650 000 | 2,06% | Option de vente |
| DIMENSIONAL FUND ADVISORS LP | $43 707 751 | 640 219 | 2,03% | Actions |
| GOLDMAN SACHS GROUP INC | $42 579 111 | 623 687 | 1,98% | Actions |
| BANK OF AMERICA CORP /DE/ | $42 152 219 | 617 434 | 1,96% | Actions |
| Casdin Capital, LLC | $32 769 600 | 480 000 | 1,52% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $32 631 831 | 477 982 | 1,52% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $25 396 440 | 372 000 | 1,18% | Option d'achat |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24 563 546 | 359 800 | 1,14% | Option de vente |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $23 211 800 | 340 000 | 1,08% | Actions |
| Granahan Investment Management, LLC | $21 926 686 | 321 176 | 1,02% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $20 523 874 | 300 628 | 0,95% | Actions |
| Aberdeen Group plc | $15 668 170 | 229 503 | 0,73% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $15 357 337 | 224 950 | 0,71% | Actions |
| Slow Capital, Inc. | $14 832 477 | 217 262 | 0,69% | Actions |
| CITADEL ADVISORS LLC | $14 616 607 | 214 100 | 0,68% | Option d'achat |
| TCW GROUP INC | $13 101 901 | 191 913 | 0,61% | Actions |
| Douglas Lane & Associates, LLC | $11 082 952 | 162 340 | 0,51% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10 601 990 | 155 295 | 0,49% | Actions |
| RAYMOND JAMES FINANCIAL INC | $10 495 215 | 153 731 | 0,49% | Actions |
| Newtyn Management, LLC | $10 240 500 | 150 000 | 0,48% | Actions |
| 180 WEALTH ADVISORS, LLC | $8 723 113 | 127 774 | 0,41% | Actions |
| Voleon Capital Management LP | $8 264 903 | 121 062 | 0,38% | Actions |
| FMR LLC | $8 139 559 | 119 226 | 0,38% | Actions |
| WIM INVESTMENT MANAGEMENT Ltd | $7 263 928 | 106 400 | 0,34% | Actions |
| Alyeska Investment Group, L.P. | $7 168 350 | 105 000 | 0,33% | Actions |
| AMERICAN CENTURY COMPANIES INC | $6 774 228 | 99 227 | 0,31% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $5 809 000 | 85 089 | 0,27% | Actions |
| Swiss National Bank | $5 202 174 | 76 200 | 0,24% | Actions |
| Susquehanna Portfolio Strategies, LLC | $4 853 178 | 71 088 | 0,23% | Actions |
| NATIXIS | $4 794 329 | 70 226 | 0,22% | Actions |
| CITADEL ADVISORS LLC | $4 601 398 | 67 400 | 0,21% | Option de vente |
| BARCLAYS PLC | $4 557 091 | 66 751 | 0,21% | Actions |
| GAMCO INVESTORS, INC. ET AL | $4 554 497 | 66 713 | 0,21% | Actions |
| D. E. Shaw & Co., Inc. | $4 444 787 | 65 106 | 0,21% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3 810 968 | 55 822 | 0,18% | Actions |
| Allianz Asset Management GmbH | $3 810 695 | 55 818 | 0,18% | Actions |
| JANE STREET GROUP, LLC | $3 775 331 | 55 300 | 0,18% | Option d'achat |
| RHUMBLINE ADVISERS | $3 773 202 | 55 269 | 0,18% | Actions |
| Public Sector Pension Investment Board | $3 633 534 | 53 223 | 0,17% | Actions |
| Pictet Asset Management Holding SA | $3 421 492 | 50 039 | 0,16% | Actions |
| Centiva Capital, LP | $3 413 500 | 50 000 | 0,16% | Option d'achat |
| Verition Fund Management LLC | $3 334 921 | 48 849 | 0,15% | Actions |
| BlackRock, Inc. | $3 131 886 | 45 875 | 0,15% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $3 072 150 | 450 | 0,14% | Option d'achat |
| D. E. Shaw & Co., Inc. | $3 072 150 | 45 000 | 0,14% | Option de vente |
| Legal Advantage Investments, Inc. | $3 046 549 | 44 625 | 0,14% | Actions |
| HighTower Advisors, LLC | $2 769 342 | 40 565 | 0,13% | Actions |
| Rafferty Asset Management, LLC | $2 697 962 | 39 519 | 0,13% | Actions |
| Timelo Investment Management Inc. | $2 662 530 | 39 000 | 0,12% | Actions |
| ALLIANCEBERNSTEIN L.P. | $2 492 320 | 48 226 | 0,12% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 298 210 | 44 470 | 0,11% | Actions |
| Lido Advisors, LLC | $2 270 250 | 33 254 | 0,11% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $2 252 910 | 330 | 0,10% | Option de vente |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $2 211 768 | 30 719 | 0,10% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $2 133 984 | 31 258 | 0,10% | Actions |
| Summit Financial, LLC | $2 103 877 | 30 817 | 0,10% | Actions |
| GABELLI FUNDS LLC | $2 067 420 | 30 283 | 0,10% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $1 988 740 | 30 169 | 0,09% | Actions |
| OSAIC HOLDINGS, INC. | $1 906 981 | 27 934 | 0,09% | Actions |
| TWO SIGMA INVESTMENTS, LP | $1 872 305 | 27 425 | 0,09% | Actions |
| COMMERCE BANK | $1 841 993 | 26 981 | 0,09% | Actions |
| UBS Group AG | $1 835 234 | 26 882 | 0,09% | Actions |
| Concurrent Investment Advisors, LLC | $1 833 850 | 26 862 | 0,09% | Actions |
| Gem Investment Advisors, LLC | $1 828 339 | 26 781 | 0,08% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 823 765 | 26 714 | 0,08% | Actions |
| Legato Capital Management LLC | $1 804 649 | 26 434 | 0,08% | Actions |
| PVG ASSET MANAGEMENT CORP | $1 767 305 | 25 887 | 0,08% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $1 761 366 | 25 800 | 0,08% | Actions |
| IMC-Chicago, LLC | $1 710 368 | 25 053 | 0,08% | Actions |
| Jackson Hole Capital Partners, LLC | $1 705 440 | 33 000 | 0,08% | Actions |
| Sheets Smith Investment Management | $1 688 635 | 28 558 | 0,08% | Actions |
| MetLife Investment Management, LLC | $1 649 813 | 24 166 | 0,08% | Actions |
| Gotham Asset Management, LLC | $1 634 384 | 23 940 | 0,08% | Actions |
| Quantinno Capital Management LP | $1 593 922 | 23 347 | 0,07% | Actions |
| TWO SIGMA ADVISERS, LP | $1 592 060 | 18 601 | 0,07% | Actions |
| CLOUGH CAPITAL PARTNERS L P | $1 566 387 | 22 944 | 0,07% | Actions |
| STATE OF WISCONSIN INVESTMENT BOARD | $1 522 353 | 22 299 | 0,07% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1 474 427 | 21 597 | 0,07% | Actions |
| LPL Financial LLC | $1 393 254 | 20 408 | 0,06% | Actions |
| PROFUND ADVISORS LLC | $1 370 725 | 20 078 | 0,06% | Actions |
| Perigon Wealth Management, LLC | $1 348 537 | 19 753 | 0,06% | Actions |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1 271 324 | 18 622 | 0,06% | Actions |
| Invesco Ltd. | $1 117 853 | 16 374 | 0,05% | Actions |
| Bouvel Investment Partners, LLC | $1 106 998 | 16 215 | 0,05% | Actions |
| AMERIPRISE FINANCIAL INC | $1 082 216 | 15 852 | 0,05% | Actions |
| NORGES BANK | $1 077 983 | 15 790 | 0,05% | Actions |
| EXCHANGE TRADED CONCEPTS, LLC | $1 054 703 | 15 449 | 0,05% | Actions |
| STRS OHIO | $1 044 531 | 15 300 | 0,05% | Actions |
| PRUDENTIAL FINANCIAL INC | $1 006 300 | 14 740 | 0,05% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $996 469 | 14 596 | 0,05% | Actions |
Initiés de la société 8 initiés · 2 dirigeants · 5 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Joshua J. Ofman | Chief Executive Officer | 1 juin 2026 A | 402 271 | 0 | 0 | $0 |
| Andrew John Partridge | Chief Growth Officer | 4 juin 2026 S | 163 738 | 0 | 1 | $-91 070 |
| William J Chase | Administrateur | 15 juillet 2026 A | 42 978 | 0 | 0 | $0 |
| Steven Mizell | Administrateur | 15 juillet 2026 A | 42 830 | 0 | 0 | $0 |
| Gregory L Summe | Administrateur | 15 juillet 2026 A | 45 672 | 0 | 0 | $0 |
| Sarah Krevans | Administrateur | 18 juin 2026 A | 42 628 | 0 | 0 | $0 |
| ILLUMINA, INC. | Détenteur de 10% | 17 novembre 2025 S | 3 502 126 | 0 | 1 | $-79 850 000 |
| Chun R Ding | Détenteur de 10% | 9 octobre 2024 P | 3 644 855 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 50 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,90% | 18 597 NS | 30 avril 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,63% | 59 651 NS | 30 avril 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,21% | 87 481 SH | 8 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,20% | 2 336 SH | 8 août 2026 | Quotidien |
| IBB · iShares Trust | 0,19% | 291 644 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,18% | 36 116 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,17% | 67 501 NS | 31 mai 2026 | N-PORT |
| IWN · iShares Trust | 0,17% | 385 837 SH | 8 août 2026 | Quotidien |
| ESSC · Strategy Shares | 0,15% | 712 NS | 30 avril 2026 | N-PORT |
| BIB · ProShares Trust | 0,14% | 1 439 NS | 31 mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 237 749 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,08% | 1 053 632 SH | 8 août 2026 | Quotidien |
| GSSC · Goldman Sachs ETF Trust | 0,08% | 11 051 NS | 31 mai 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,08% | 1 185 NS | 30 avril 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 9 665 NS | 30 avril 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 1 654 NS | 31 mai 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 2 459 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,06% | 15 208 NS | 30 avril 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 22 118 SH | 8 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,05% | 117 357 NS | 30 avril 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 143 168 NS | 31 mai 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 6 428 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,04% | 114 187 SH | 8 août 2026 | Quotidien |
| UWM · ProShares Trust | 0,04% | 1 294 NS | 31 mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,04% | 1 688 SH | 8 août 2026 | Quotidien |
| ISCV · iShares Trust | 0,04% | 3 927 SH | 8 août 2026 | Quotidien |
| SMLF · iShares Trust | 0,03% | 20 757 SH | 8 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 16 096 NS | 30 avril 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 374 291 SH | 8 août 2026 | Quotidien |
| URTY · ProShares Trust | 0,03% | 1 307 NS | 31 mai 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 2 078 SH | 8 août 2026 | Quotidien |
| DXUV · Dimensional ETF Trust | 0,02% | 1 178 NS | 30 avril 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1 399 NS | 31 mai 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,01% | 23 351 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 33 NS | 31 mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4 910 NS | 30 avril 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 11 015 NS | 31 mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 51 657 NS | 30 avril 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 11 704 SH | 8 août 2026 | Quotidien |
| IETC · iShares U.S. ETF Trust | 0,00% | 375 SH | 8 août 2026 | Quotidien |
| ACVF · ETF Opportunities Trust | 0,00% | 82 NS | 30 avril 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 45 817 SH | 8 août 2026 | Quotidien |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 192 NS | 31 mai 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 17 955 NS | 31 mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 9 362 NS | 30 avril 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4 660 NS | 30 avril 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 3 550 NS | 30 avril 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,00% | 321 NS | 30 avril 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 228 926 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 407 SH | 8 août 2026 | Quotidien |